Upadacitinib in patients from China, Brazil, and South Korea with rheumatoid arthritis and an inadequate response to conventional therapy

por Zeng, Xiaofeng, Zhao, Dongbao, Radominski, Sebastiao C., Keiserman, Mauro, Lee, Chang K., Meerwein, Sebastian, Enejosa, Jeffrey, Sui, Yunxia, Mohamed, Mohamed‐Eslam F., Park, Won
Publicado 2021

A comparative study of PF‐06438179/GP1111 (an infliximab biosimilar) and reference infliximab in patients with moderate to severe active rheumatoid arthritis: A subgroup analysis

por Kameda, Hideto, Uechi, Eishi, Atsumi, Tatsuya, Abud‐Mendoza, Carlos, Kamei, Kazumasa, Matsumoto, Tsugumi, Ponce de Leon, Dario, Rehman, Muhammad I., Zhang, Min, Radominski, Sebastiao C.
Publicado 2020

Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY

por Strand, Vibeke, Tundia, Namita, Wells, Alvin, Buch, Maya H, Radominski, Sebastiao C, Camp, Heidi S, Friedman, Alan, Suboticki, Jessica L, Dunlap, Kendall, Goldschmidt, Debbie, Bergman, Martin
Publicado 2020

Long-term Efficacy, Safety, and Immunogenicity of the Infliximab (IFX) Biosimilar, PF-06438179/GP1111, in Patients with Rheumatoid Arthritis After Switching from Reference IFX or C...

por Cohen, Stanley B., Radominski, Sebastiao C., Kameda, Hideto, Kivitz, Alan J., Tee, Michael, Cronenberger, Carol, Zhang, Min, Hackley, Sarah, Rehman, Muhammad I., von Richter, Oliver, Alten, Rieke
Publicado 2020

Randomised, double-blind, phase III study comparing the infliximab biosimilar, PF-06438179/GP1111, with reference infliximab: efficacy, safety and immunogenicity from week 30 to we...

por Alten, Rieke, Batko, Bogdan, Hala, Tomas, Kameda, Hideto, Radominski, Sebastiao C, Tseluyko, Vira, Babic, Goran, Cronenberger, Carol, Hackley, Sarah, Rehman, Muhammad, von Richter, Oliver, Zhang, Min, Cohen, Stanley
Publicado 2019

Subcutaneous Tocilizumab Versus Placebo in Combination With Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis

por Kivitz, Alan, Olech, Ewa, Borofsky, Michael, Zazueta, Beatriz M, Navarro-Sarabia, Federico, Radominski, Sebastião C, Merrill, Joan T, Rowell, Lucy, Nasmyth-Miller, Clare, Bao, Min, Wright, Stephen, Pope, Janet E
Publicado 2014

A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthrit...

por Cohen, Stanley B., Alten, Rieke, Kameda, Hideto, Hala, Tomas, Radominski, Sebastiao C., Rehman, Muhammad I., Palaparthy, Ramesh, Schumacher, Karl, Schmitt, Susanne, Hua, Steven Y., Ianos, Claudia, Lea Sewell, K.
Publicado 2018

Tofacitinib, an oral Janus kinase inhibitor, in patients from Brazil with rheumatoid arthritis: Pooled efficacy and safety analyses

por Lomonte, Andrea B.V., Radominski, Sebastião C., Marcolino, Flora M.D., Brenol, Claiton V., Zerbini, Cristiano A.F., García, Erika G., Akylbekova, Ermeg L., Rojo, Ricardo, de Leon, Dario Ponce
Publicado 2018

Safety of upadacitinib in Latin American patients with rheumatoid arthritis: an integrated safety analysis of the SELECT phase 3 clinical program

por Kakehasi, Adriana Maria, Radominski, Sebastião Cezar, Baravalle, Marcos Daniel, Palazuelos, Fedra Consuelo Irazoque, Garcia-Garcia, Conrado, Arruda, Maysa Silva, Curi, Marco, Liu, John, Qiao, Meihua, Velez-Sanchez, Patricia, Vargas, Juan Ignacio
Publicado 2023

Five Years of Cenosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the First Two Years of the FREEDOM Extension

por Papapoulos, Socrates, Chapurlat, Roland, Libanati, Cesar, Brandi, Maria Luisa, Brown, Jacques P, Czerwiński, Edward, Krieg, Marc-Antoine, Man, Zulema, Mellström, Dan, Radominski, Sebastião C, Reginster, Jean-Yves, Resch, Heinrich, Ivorra, José A Román, Roux, Christian, Vittinghoff, Eric, Austin, Matthew, Daizadeh, Nadia, Bradley, Michelle N, Grauer, Andreas, Cummings, Steven R, Bone, Henry G
Publicado 2012

Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with...

por Park, Won, Suh, Chang-Hee, Shim, Seung Cheol, Molina, Francisco Fidencio Cons, Jeka, Slawomir, Medina-Rodriguez, Francisco G., Hrycaj, Pawel, Wiland, Piotr, Lee, Eun Young, Shesternya, Pavel, Kovalenko, Volodymyr, Myasoutova, Leysan, Stanislav, Marina, Radominski, Sebastiao, Lim, Mie Jin, Choe, Jung-Yoon, Lee, Sang Joon, Lee, Sung Young, Kim, Sung Hwan, Yoo, Dae Hyun
Publicado 2017

The Effect of Three or Six Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the FREEDOM Extension

por Bone, Henry G., Chapurlat, Roland, Brandi, Maria-Luisa, Brown, Jacques P., Czerwiński, Edward, Krieg, Marc-Antoine, Mellström, Dan, Radominski, Sebastião C., Reginster, Jean-Yves, Resch, Heinrich, Ivorra, Jose A. Román, Roux, Christian, Vittinghoff, Eric, Daizadeh, Nadia S., Wang, Andrea, Bradley, Michelle N., Franchimont, Nathalie, Geller, Michelle L., Wagman, Rachel B., Cummings, Steven R., Papapoulos, Socrates
Publicado 2013

A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis

por Yoo, Dae Hyun, Suh, Chang-Hee, Shim, Seung Cheol, Jeka, Slawomir, Cons-Molina, Francisco Fidencio, Hrycaj, Pawel, Wiland, Piotr, Lee, Eun Young, Medina-Rodriguez, Francisco G, Shesternya, Pavel, Radominski, Sebastiao, Stanislav, Marina, Kovalenko, Volodymyr, Sheen, Dong Hyuk, Myasoutova, Leysan, Lim, Mie Jin, Choe, Jung-Yoon, Lee, Sang Joon, Lee, Sung Young, Kwon, Taek Sang, Park, Won
Publicado 2017

Efficacy, Safety and Pharmacokinetics of Up to Two Courses of the Rituximab Biosimilar CT-P10 Versus Innovator Rituximab in Patients with Rheumatoid Arthritis: Results up to Week 7...

por Yoo, Dae Hyun, Suh, Chang-Hee, Shim, Seung Cheol, Jeka, Slawomir, Molina, Francisco Fidencio Cons, Hrycaj, Pawel, Wiland, Piotr, Lee, Eun Young, Medina-Rodriguez, Francisco G., Shesternya, Pavel, Radominski, Sebastiao, Stanislav, Marina, Kovalenko, Volodymyr, Sheen, Dong Hyuk, Myasoutova, Leysan, Lim, Mie Jin, Choe, Jung-Yoon, Lee, Sang Joon, Lee, Sung Young, Kim, Sung Hwan, Park, Won
Publicado 2017

Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials

por Ruperto, Nicolino, Brunner, Hermine I, Quartier, Pierre, Constantin, Tamàs, Wulffraat, Nico M, Horneff, Gerd, Kasapcopur, Ozgur, Schneider, Rayfel, Anton, Jordi, Barash, Judith, Berner, Reinhard, Corona, Fabrizia, Cuttica, Ruben, Fouillet-desjonqueres, Marine, Fischbach, Michel, Foster, Helen E, Foell, Dirk, Radominski, Sebastião C, Ramanan, Athimalaipet V, Trauzeddel, Ralf, Unsal, Erbil, Levy, Jérémy, Vritzali, Eleni, Martini, Alberto, Lovell, Daniel J
Publicado 2018

Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort

por Gomides, Ana Paula Monteiro, de Albuquerque, Cleandro Pires, Santos, Ana Beatriz Vargas, Amorim, Rodrigo Balbino Chaves, Bértolo, Manoel Barros, Júnior, Paulo Louzada, Santos, Isabela Araújo, Giorgi, Rina Dalva Neubarth, Sacilotto, Nathalia de Carvalho, Radominski, Sebastião Cezar, Borghi, Fernanda Maria, Guimarães, Maria Fernanda B. Resende, Pinto, Maria Raquel da Costa, Resende, Gustavo Gomes, Bonfiglioli, Karina Rossi, da Silva, Henrique Carriço, Sauma, Maria de Fátima Lobato da Cunha, Sauma, Marcel Lobato, de Medeiros, Júlia Brito, Pereira, Ivânio Alves, de Castro, Gláucio Ricardo Wernwer, Brenol, Claiton Viegas, Xavier, Ricardo Machado, da Mota, Licia Maria Henrique, Pinheiro, Geraldo da Rocha Castelar
Publicado 2019

Correction: Causes of synthetic disease-modifying drug discontinuation in rheumatoid arthritis: Data from a large real-life cohort

por Gomides, Ana Paula Monteiro, de Albuquerque, Cleandro Pires, Santos, Ana Beatriz Vargas, Amorim, Rodrigo Balbino Chaves, Bértolo, Manoel Barros, Júnior, Paulo Louzada, Santos, Isabela Araújo, Giorgi, Rina Dalva Neubarth, Sacilotto, Nathalia de Carvalho, Radominski, Sebastião Cezar, Borghi, Fernanda Maria, Guimarães, Maria Fernanda B. Resende, Pinto, Maria Raquel da Costa, Resende, Gustavo Gomes, Bonfiglioli, Karina Rossi, da Silva, Henrique Carriço, Sauma, Maria de Fátima Lobato da Cunha, Sauma, Marcel Lobato, de Medeiros, Júlia Brito, Pereira, Ivânio Alves, de Castro, Gláucio Ricardo Werner, Brenol, Claiton Viegas, Xavier, Ricardo Machado, da Mota, Licia Maria Henrique, Pinheiro, Geraldo da Rocha Castelar
Publicado 2019

Discordance between the patient’s and physician’s global assessment in rheumatoid arthritis: Data from the REAL study—Brazil

por Guimarães, Maria Fernanda Brandão Resende, Pinto, Maria Raquel da Costa, Resende, Gustavo Gomes, Machado, Carla Jorge, Vargas-Santos, Ana Beatriz, Amorim, Rodrigo Balbino Chaves, Gomides, Ana Paula Monteiro, de Albuquerque, Cleandro Pires, Bértolo, Manoel Barros, Júnior, Paulo Louzada, Santos, Isabela Araújo, Giorgi, Rina Dalva Neubarth, Saciloto, Nathalia de Carvalho, Radominski, Sebastião Cezar, Borghi, Fernanda Maria, Bonfiglioli, Karina Rossi, da Silva, Henrique Carriço, Sauma, Maria de Fátima L. da Cunha, Sauma, Marcel Lobato, de Medeiros, Júlia Brito, Pereira, Ivânio Alves, de Castro, Gláucio Ricardo Werner, Brenol, Claiton Viegas, Xavier, Ricardo Machado, Mota, Licia Maria Henrique, Castelar-Pinheiro, Geraldo da Rocha
Publicado 2020

Comparison of rheumatoid arthritis composite disease activity indices and residual activity in a Brazilian multicenter study- REAL study

por Santos, Isabela Araújo, Donizeti Ribeiro de Oliveira, Renê, Couto Luna Almeida, Sergio, Vargas-Santos, Ana Beatriz, Balbino Chaves Amorim, Rodrigo, Monteiro Gomides, Ana Paula, de Albuquerque, Cleandro Pires, Barros Bertolo, Manoel, Brandão Resende Guimarães, Maria Fernanda, da Costa Pinto, Maria Raquel, Gomes Resende, Gustavo, Dalva Neubarth Giorgi, Rina, de Carvalho Saciloto, Nathalia, Radominski, Sebastião Cezar, Borghi, Fernanda Maria, Rossi Bonfiglioli, Karina, Carrico da Silva, Henrique, de Fatima L. da Cunha Sauma, Maria, Alves Pereira, Ivanio, Werner de Castro, Glaucio Ricardo, Viegas Brenol, Claiton, Machado Xavier, Ricardo, Maria Henrique Mota, Licia, Louzada-Junior, Paulo, da Rocha Castelar-Pinheiro, Geraldo
Publicado 2022

Fenebrutinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double‐Blind, Phase II Trial

por Cohen, Stanley, Tuckwell, Katie, Katsumoto, Tamiko R., Zhao, Rui, Galanter, Joshua, Lee, Chin, Rae, Julie, Toth, Balazs, Ramamoorthi, Nandhini, Hackney, Jason A., Berman, Alberto, Damjanov, Nemanja, Fedkov, Dmytro, Jeka, Slawomir, Chinn, Leslie W., Townsend, Michael J., Morimoto, Alyssa M., Genovese, Mark C., Berman, Alberto, Porto, Alejandro, Granel, Amelia, Asnal, Cecilia, Mysler, Eduardo Fabian, Testa, Gladys Alicia, Zamora, Jose Luis Velasco, Moreno, Jose Luis Cristian, Gulin, Juan Pablo, Hofman, Julio, Ulla, Maria Rosa, Sabelli, Mirtha, Mannucci, Pablo Alejandro, Maid, Pablo Jorge, Melazzi, Ana Cláudia Cauceglia, Scotton, Antônio Scafuto, Ximenes, Antônio Carlos, Funes, Elisete, Gimenez, Emerson Alves, Marcolino, Flora Maria D’Andrea, Neto, João Francisco Marques, Keiserman, Mauro Waldemar, Radominski, Sebastião Cézar, Lima, Sônia Maria Alvarenga Anti Loduca, Pavan, Thaís Rohde, Azevedo, Valderílio Feijó, Koleva, Aneliya, Toncheva, Antoaneta, Bichovska, Daniela, Ivanova, Delina, Penev, Dimitar, Dimitrov, Emil, Mihaylova, Mariyana, Kapandjieva, Nadezhda, Marinova, Natalia, Aleksieva, Tanya, Tsvetanova, Tanya, Petranova, Tsvetanka, Popova, Valentina, Spasov, Yuliy, Toro, Carlos Enrique, Arteaga Unigarro, Carlos Ernesto, Jauregui, Edwin, Hernandez, Javier Dario Marquez, Raad, Juan Jose Jaller, Sanchez, Patricia Julieta Velez, Lee, Chang Keun, Suh, Chang‐Hee, Lee, Eun Young, Lee, Sang‐Heon, Kang, Seong Wook, Lee, Shin‐Seok, Lee, Yun Jong, Montiel, Beatriz Elena Zazueta, Pinzon de la O, Blanca Irma, Friedmann, Daniel Xibille, Lopez, Francisco Rosas, Torres, Isaura Rodriguez, Quezada, Luis Jara, Ceceña, Marco Maradiaga, Hernandez, Miguel Cortes, Salinas, Miguel Saavedra, Rapa, Agnieszka, Pawtel, Agnieszka, Zielinska, Agnieszka, Dudek, Anna, Rychlewska‐Hanczewska, Anna, Strzelecka, Anna, Racewicz, Artur, Stasiuk, Barbara, Gruszecka, Katarzyna, Dworak, Krystyna, Jeka, Slawomir, Lowenhoff, Tomasz, Maslyanskiy, Alexey, Rebrov, Andrey, Krechikova, Diana, Zhugrova, Elena, Shmidt, Evgeniya, Matsievskaya, Galina, Vinogradova, Irina, Ler, Irina, Eliseeva, Larisa, Savina, Ludmila, Stanislav, Marina, Sandin, Mikhail, Zyablova, Natalia, Korshunov, Nikolay, Mosesova, Nino, Polovnikova, Oksana, Nesmeyanova, Olga, Samigullina, Ruzana, Moiseev, Sergey, Noskov, Sergey, Raskina, Tatiana, Popova, Tatiana, Marchenko, Valeriy, Jovanovski, Aleksandar, Stamenkovic, Bojana, Ristic, Gorica, Lazarevic, Milijanka, Veselinovic, Mirjana, Vujasinovic‐Stupar, Nada, Damjanov, Nemanja, Ostojic, Predrag, Yagensky, Andriy, Gnylorybov, Andriy, Rekalov, Dmytro, Reshotko, Dmytroo, Fedkov, Dmytro, Dzyak, Georgiy, Gasanov, Iurii, Khimion, Ludmila, Stanislavchuk, Mykola, Prykhodko, Natalya, Nadashkevych, Oleg, Bortkevych, Oleg, Abrahamovych, Orest, Yatsyshyn, Roman, Turyanytsya, Samvel, Smiyan, Svitlana, Vizir, Vadym, Kachur, Victoria, Tseluyko, Vira, Povoroznyuk, Vladyslav, Koshlia, Volodymyr, Zhdan, Vyacheslav, Lymar, Yurii, Mostovoy, Yuriy, Hawkes, Angela, Mabaquiao, Arthur, Chu, Cong‐Qiu, Scoville, Craig, Wyatt, David, Weinstein, Debra, McIlwain, Harris, Vo, Jacqueline, Poiley, Jeffrey, Forstot, Joseph, Dao, Kathryn, Turner, Mark, Genovese, Mark, Borofsky, Michael, Caldron, Paul, Waller, Philip, Levin, Robert, Metyas, Samy, Stein, Scott, Shroff, Sharukh, Pang, Shirley, Cohen, Stanley, Syed, Tauseef, Chindalore, Vishala
Publicado 2020